Amgen (AMGN) |
United States |
$143.922B |
15.06 |
Bristol Myers Squibb (BMY) |
United States |
$142.033B |
9.87 |
CSL (CSLLY) |
Australia |
$92.235B |
0.00 |
Gilead Sciences (GILD) |
United States |
$81.700B |
9.15 |
Moderna (MRNA) |
United States |
$59.963B |
0.00 |
Illumina (ILMN) |
United States |
$58.820B |
89.59 |
Vertex Pharmaceuticals (VRTX) |
United States |
$55.890B |
23.86 |
Regeneron Pharmaceuticals (REGN) |
United States |
$51.106B |
16.70 |
Biogen (BIIB) |
United States |
$40.550B |
8.11 |
Alexion Pharmaceuticals (ALXN) |
United States |
$33.797B |
13.16 |
BioNTech SE (BNTX) |
Germany |
$31.311B |
810.25 |
BeiGene (BGNE) |
Cayman Islands |
$27.539B |
0.00 |
Seagen (SGEN) |
United States |
$25.544B |
43.76 |
Genmab (GMAB) |
Denmark |
$22.726B |
31.79 |
Exact Sciences (EXAS) |
United States |
$21.644B |
0.00 |
Genmab (GNMSF) |
Denmark |
$21.134B |
5.01 |
Horizon Therapeutics Public (HZNP) |
Ireland |
$20.530B |
23.55 |
SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$18.882B |
0.00 |
Bio-Rad Laboratories (BIO.B) |
United States |
$17.932B |
57.06 |
Incyte (INCY) |
United States |
$17.730B |
0.00 |
Bio-Techne Corp (TECH) |
United States |
$16.274B |
93.21 |
Alnylam Pharmaceuticals (ALNY) |
United States |
$15.983B |
0.00 |
Guardant Health (GH) |
United States |
$15.751B |
0.00 |
Novavax (NVAX) |
United States |
$14.377B |
0.00 |
Zai Lab (ZLAB) |
China |
$14.289B |
0.00 |
BioMarin Pharmaceutical (BMRN) |
United States |
$14.141B |
112.71 |
ARGENX SE-ADR (ARGX) |
Netherlands |
$13.800B |
0.00 |
QIAGEN (QGEN) |
Netherlands |
$11.862B |
24.20 |
Repligen (RGEN) |
United States |
$11.659B |
128.23 |
CRISPR Therapeutics AG (CRSP) |
Switzerland |
$9.118B |
0.00 |
Mirati Therapeutics (MRTX) |
United States |
$8.091B |
0.00 |
AbCellera Biologics (ABCL) |
|
$7.616B |
0.00 |
Acceleron Pharma (XLRN) |
United States |
$7.462B |
0.00 |
Fate Therapeutics (FATE) |
United States |
$7.400B |
0.00 |
Exelixis (EXEL) |
United States |
$7.307B |
66.91 |
Ultragenyx Pharmaceutical (RARE) |
United States |
$7.136B |
0.00 |
Twist Bioscience (TWST) |
United States |
$6.850B |
0.00 |
Ascendis Pharma (ASND) |
Denmark |
$6.709B |
0.00 |
Denali Therapeutics (DNLI) |
United States |
$6.540B |
207.92 |
Halozyme Therapeutics (HALO) |
United States |
$6.374B |
49.42 |
Adaptive Biotechnologies (ADPT) |
United States |
$6.041B |
0.00 |
NeoGenomics (NEO) |
United States |
$5.795B |
707.29 |
Vir Biotechnology (VIR) |
United States |
$5.744B |
0.00 |
Sarepta Therapeutics (SRPT) |
United States |
$5.559B |
0.00 |
Blueprint Medicines (BPMC) |
United States |
$5.395B |
17.76 |
Galapagos (GLPG) |
Belgium |
$5.130B |
0.00 |
SWEDISH ORP BIO (BIOVF) |
Sweden |
$5.086B |
15.99 |
Intellia Therapeutics (NTLA) |
United States |
$4.794B |
0.00 |
Atea Pharmaceuticals (AVIR) |
United States |
$4.734B |
0.00 |
Beam Therapeutics (BEAM) |
United States |
$4.673B |
0.00 |
Biohaven Pharmaceutical Holding (BHVN) |
United States |
$4.515B |
0.00 |
Certara (CERT) |
United States |
$4.234B |
0.00 |
Arena Pharmaceuticals (ARNA) |
United States |
$4.006B |
0.00 |
Emergent Biosolutions (EBS) |
United States |
$3.898B |
9.27 |
I-Mab (IMAB) |
China |
$3.571B |
0.00 |
Legend Biotech (LEGN) |
United States |
$3.519B |
0.00 |
Seer (SEER) |
|
$3.467B |
0.00 |
SpringWorks Therapeutics (SWTX) |
United States |
$3.399B |
0.00 |
Apellis Pharmaceuticals (APLS) |
United States |
$3.395B |
0.00 |
ACADIA Pharmaceuticals (ACAD) |
United States |
$3.297B |
0.00 |
Insmed (INSM) |
United States |
$3.272B |
0.00 |
Berkeley Lights (BLI) |
United States |
$3.233B |
0.00 |
Reata Pharmaceuticals (RETA) |
United States |
$3.130B |
0.00 |
BAVARIAN NORDIC (BVNRY) |
Denmark |
$3.022B |
42.81 |
Alkermes (ALKS) |
Ireland |
$3.003B |
0.00 |
Arvinas (ARVN) |
United States |
$2.998B |
0.00 |
MorphoSys AG (MOR) |
Germany |
$2.942B |
44.72 |
Editas Medicine (EDIT) |
United States |
$2.806B |
0.00 |
Vericel (VCEL) |
United States |
$2.609B |
1132.00 |
Intra-Cellular Therapies (ITCI) |
United States |
$2.511B |
0.00 |
Deciphera Pharmaceuticals (DCPH) |
United States |
$2.503B |
0.00 |
Global Blood Therapeutics (GBT) |
United States |
$2.497B |
0.00 |
Amicus Therapeutics (FOLD) |
United States |
$2.461B |
0.00 |
Ligand Pharmaceuticals (LGND) |
United States |
$2.442B |
46.23 |
Arcus Biosciences (RCUS) |
United States |
$2.300B |
0.00 |
ALX Oncology Holdings (ALXO) |
United States |
$2.291B |
0.00 |
Myriad Genetics (MYGN) |
United States |
$2.129B |
0.00 |
PHARMA MAR SA (PHMMF) |
Spain |
$2.055B |
0.00 |
Dicerna Pharmaceuticals (DRNA) |
United States |
$2.048B |
0.00 |
Amarin (AMRN) |
Ireland |
$1.999B |
0.00 |
Revance Therapeutics (RVNC) |
United States |
$1.984B |
0.00 |
Sorrento Therapeutics (SRNE) |
United States |
$1.946B |
0.00 |
Seres Therapeutics (MCRB) |
United States |
$1.923B |
0.00 |
Bionano Genomics (BNGO) |
United States |
$1.920B |
0.00 |
Bluebird Bio (BLUE) |
United States |
$1.902B |
0.00 |
Heska (HSKA) |
United States |
$1.882B |
0.00 |
NGM Biopharmaceuticals (NGM) |
United States |
$1.874B |
0.00 |
Morphic Holding (MORF) |
United States |
$1.871B |
0.00 |
Genetron Holdings (GTH) |
China |
$1.777B |
0.00 |
Five Prime Therapeutics (FPRX) |
United States |
$1.767B |
0.00 |
Castle Biosciences (CSTL) |
United States |
$1.713B |
0.00 |
Cytokinetics (CYTK) |
United States |
$1.710B |
0.00 |
Sangamo Therapeutics (SGMO) |
United States |
$1.621B |
0.00 |
Harmony Biosciences Holdings (HRMY) |
United States |
$1.619B |
0.00 |
UniQure (QURE) |
Netherlands |
$1.569B |
0.00 |
ADC Therapeutics SA (ADCT) |
Switzerland |
$1.566B |
0.00 |
Codexis (CDXS) |
United States |
$1.559B |
0.00 |
Travere Therapeutics (TVTX) |
United States |
$1.513B |
0.00 |
Keros Therapeutics (KROS) |
United States |
$1.490B |
0.00 |
REGENXBIO (RGNX) |
United States |
$1.473B |
0.00 |
Precigen (PGEN) |
United States |
$1.456B |
0.00 |
Immunocore Holdings (IMCR) |
United Kingdom |
$1.423B |
0.00 |
Zealand Pharma (ZEAL) |
Denmark |
$1.423B |
0.00 |
Alector (ALEC) |
United States |
$1.395B |
0.00 |
Kymera Therapeutics (KYMR) |
United States |
$1.393B |
0.00 |
MiMedx (MDXG) |
United States |
$1.380B |
0.00 |
Cara Therapeutics (CARA) |
United States |
$1.371B |
343.63 |
C4 Therapeutics (CCCC) |
United States |
$1.362B |
0.00 |
Shattuck Labs (STTK) |
United States |
$1.341B |
0.00 |
Forma Therapeutics Holdings (FMTX) |
United States |
$1.312B |
0.00 |
Zymeworks (ZYME) |
Canada |
$1.289B |
0.00 |
Ocugen (OCGN) |
United States |
$1.262B |
0.00 |
Repare Therapeutics (RPTX) |
Canada |
$1.200B |
0.00 |
Nurix Therapeutics (NRIX) |
United States |
$1.177B |
0.00 |
Northwest Biotherapeutics (NWBO) |
United States |
$1.176B |
0.00 |
Avid Bioservices (CDMO) |
United States |
$1.170B |
0.00 |
Zealand Pharma (ZLDPF) |
Denmark |
$1.167B |
0.00 |
Nkarta (NKTX) |
United States |
$1.165B |
0.00 |
Dynavax Technologies (DVAX) |
United States |
$1.128B |
0.00 |
Mesoblast (MESO) |
Australia |
$1.121B |
0.00 |
Protagonist Therapeutics (PTGX) |
United States |
$1.120B |
0.00 |
Mersana Therapeutics (MRSN) |
United States |
$1.116B |
0.00 |
Y-mAbs Therapeutics (YMAB) |
United States |
$1.113B |
0.00 |
OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$1.093B |
0.00 |
Pliant Therapeutics (PLRX) |
United States |
$1.081B |
0.00 |
MannKind (MNKD) |
United States |
$1.049B |
0.00 |
Curis (CRIS) |
United States |
$1.041B |
0.00 |
Arcturus Therapeutics Holdings (ARCT) |
United States |
$1.037B |
0.00 |
G1 THERAPEUTICS (GTHX) |
United States |
$1.019B |
0.00 |
Coherus BioSciences (CHRS) |
United States |
$1.018B |
8.24 |
Syndax Pharmaceuticals (SNDX) |
United States |
$0.994B |
0.00 |
Scholar Rock Holding (SRRK) |
United States |
$0.970B |
0.00 |
Prothena (PRTA) |
Ireland |
$0.935B |
0.00 |
Vanda Pharmaceuticals (VNDA) |
United States |
$0.895B |
37.93 |
Adverum Biotechnologies (ADVM) |
United States |
$0.882B |
0.00 |
Sutro Biopharma (STRO) |
United States |
$0.879B |
0.00 |
Affimed (AFMD) |
Germany |
$0.874B |
0.00 |
Merus (MRUS) |
Netherlands |
$0.863B |
0.00 |
Celldex Therapeutics (CLDX) |
United States |
$0.851B |
0.00 |
Pharming Group (PHAR) |
Netherlands |
$0.846B |
0.00 |
Inhibrx (INBX) |
United States |
$0.841B |
0.00 |
Epizyme (EPZM) |
United States |
$0.833B |
0.00 |
Cellectis S.A (CLLS) |
France |
$0.831B |
0.00 |
Orchard Therapeutics (ORTX) |
United Kingdom |
$0.824B |
0.00 |
Pharming Group (PHGUF) |
Netherlands |
$0.820B |
21.83 |
KaloBios Pharmaceuticals (HGEN) |
United States |
$0.813B |
0.00 |
Bolt Biotherapeutics (BOLT) |
United States |
$0.798B |
0.00 |
Prometheus Biosciences (RXDX) |
United States |
$0.793B |
0.00 |
Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.788B |
0.00 |
Lexicon Pharmaceuticals (LXRX) |
United States |
$0.751B |
0.00 |
Avidity Biosciences (RNA) |
United States |
$0.748B |
0.00 |
ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.727B |
0.00 |
VBI Vaccines (VBIV) |
United States |
$0.724B |
0.00 |
Intercept Pharmaceuticals (ICPT) |
United States |
$0.699B |
0.00 |
Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.677B |
0.00 |
Xenon Pharmaceuticals (XENE) |
Canada |
$0.649B |
0.00 |
DBV Technologies S.A (DBVT) |
France |
$0.647B |
0.00 |
Clovis Oncology (CLVS) |
United States |
$0.642B |
0.00 |
Sinovac Biotech (SVA) |
China |
$0.640B |
35.94 |
Cel-Sci (CVM) |
United States |
$0.638B |
0.00 |
ALBIREO PHARMA (ALBO) |
United States |
$0.623B |
0.00 |
Kadmon Holdings (KDMN) |
United States |
$0.622B |
0.00 |
Starpharma Holdings (SPHRY) |
Australia |
$0.609B |
0.00 |
ChromaDex (CDXC) |
United States |
$0.603B |
0.00 |
MeiraGTx Holdings (MGTX) |
United States |
$0.602B |
0.00 |
Compugen (CGEN) |
Israel |
$0.597B |
0.00 |
IDEAYA Biosciences (IDYA) |
United States |
$0.584B |
0.00 |
Adagene (ADAG) |
|
$0.583B |
0.00 |
Anika Therapeutics (ANIK) |
United States |
$0.579B |
192.48 |
AnaptysBio (ANAB) |
United States |
$0.561B |
0.00 |
Agenus (AGEN) |
United States |
$0.555B |
0.00 |
Inventiva S.A (IVA) |
France |
$0.540B |
0.00 |
Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.539B |
0.00 |
AMMO (POWW) |
United States |
$0.518B |
0.00 |
Neoleukin Therapeutics (NLTX) |
United States |
$0.517B |
0.00 |
Amryt Pharma (AMYT) |
United Kingdom |
$0.492B |
0.00 |
XBiotech (XBIT) |
United States |
$0.491B |
0.00 |
Precision BioSciences (DTIL) |
United States |
$0.490B |
0.00 |
AC Immune SA (ACIU) |
Switzerland |
$0.480B |
0.00 |
RAPT THERAPTICS (RAPT) |
United States |
$0.480B |
0.00 |
Forte Biosciences (FBRX) |
United States |
$0.468B |
0.00 |
Fortress Biotech (FBIO) |
United States |
$0.468B |
0.00 |
Verastem (VSTM) |
United States |
$0.464B |
0.00 |
Geron (GERN) |
United States |
$0.456B |
0.00 |
CytomX Therapeutics (CTMX) |
United States |
$0.442B |
0.00 |
Kala Pharmaceuticals (KALA) |
United States |
$0.441B |
0.00 |
Selecta Biosciences (SELB) |
United States |
$0.438B |
0.00 |
AquaBounty Technologies (AQB) |
United States |
$0.438B |
0.00 |
Opthea (OPT) |
Australia |
$0.434B |
0.00 |
Gritstone Oncology (GRTS) |
United States |
$0.433B |
0.00 |
XOMA (XOMA) |
United States |
$0.423B |
93.82 |
Angion Biomedica (ANGN) |
United States |
$0.421B |
0.00 |
ANI Pharmaceuticals (ANIP) |
United States |
$0.408B |
11.39 |
Adicet Bio (ACET) |
United States |
$0.404B |
0.00 |
SESEN BIO, INC (SESN) |
United States |
$0.395B |
0.00 |
Lineage Cell Therapeutics (LCTX) |
United States |
$0.394B |
0.00 |
Paratek Pharmaceuticals (PRTK) |
United States |
$0.390B |
0.00 |
Syros Pharmaceuticals (SYRS) |
United States |
$0.390B |
0.00 |
Seelos Therapeutics (SEEL) |
United States |
$0.386B |
0.00 |
Spero Therapeutics (SPRO) |
United States |
$0.384B |
0.00 |
Puma Biotechnology (PBYI) |
United States |
$0.382B |
0.00 |
Fulcrum Therapeutics (FULC) |
United States |
$0.376B |
0.00 |
Athersys (ATHX) |
United States |
$0.372B |
0.00 |
Athenex (ATNX) |
United States |
$0.372B |
0.00 |
UROGEN PHARMA (URGN) |
United States |
$0.365B |
0.00 |
SQZ Biotechnologies (SQZ) |
United States |
$0.363B |
0.00 |
Nabriva Therapeutics AG (NBRV) |
Ireland |
$0.363B |
0.00 |
Theratechnologies (THTX) |
Canada |
$0.359B |
0.00 |
CorMedix Inc (CRMD) |
United States |
$0.356B |
0.00 |
Aeglea BioTherapeutics (AGLE) |
United States |
$0.355B |
0.00 |
Cue Biopharma (CUE) |
United States |
$0.354B |
0.00 |
Oncobiologics (OTLK) |
United States |
$0.352B |
0.00 |
BioDelivery Sciences (BDSI) |
United States |
$0.348B |
13.80 |
Frequency Therapeutics (FREQ) |
United States |
$0.348B |
0.00 |
Bellus Health (BLU) |
Canada |
$0.343B |
0.00 |
Innate Pharma S.A (IPHA) |
France |
$0.340B |
0.00 |
HOOKIPA Pharma (HOOK) |
United States |
$0.324B |
0.00 |
Cardiff Oncology (CRDF) |
United States |
$0.321B |
0.00 |
Cogent Biosciences (COGT) |
United States |
$0.320B |
0.00 |
WAVE Life Sciences (WVE) |
Singapore |
$0.316B |
0.00 |
IBio (IBIO) |
United States |
$0.315B |
0.00 |
Arbutus Biopharma (ABUS) |
United States |
$0.305B |
0.00 |
Kaleido Biosciences (KLDO) |
|
$0.302B |
0.00 |
ProQR Therapeutics (PRQR) |
Netherlands |
$0.302B |
0.00 |
Codiak BioSciences (CDAK) |
United States |
$0.300B |
0.00 |
Autolus Therapeutics (AUTL) |
United Kingdom |
$0.291B |
0.00 |
PDL BioPharma (PDLI) |
United States |
$0.283B |
0.00 |
EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.280B |
0.00 |
Trevena (TRVN) |
United States |
$0.279B |
0.00 |
VTv Therapeutics (VTVT) |
United States |
$0.277B |
0.00 |
Kamada (KMDA) |
Israel |
$0.268B |
15.46 |
Protalix BioTherapeutics (PLX) |
Israel |
$0.258B |
0.00 |
NextCure (NXTC) |
United States |
$0.256B |
0.00 |
OVID THERAPEUTC (OVID) |
United States |
$0.241B |
0.00 |
Cerecor (CERC) |
United States |
$0.233B |
0.00 |
Prima BioMed (IMMP) |
Australia |
$0.232B |
0.00 |
Checkpoint Therapeutics (CKPT) |
United States |
$0.216B |
0.00 |
ADMA Biologics Inc (ADMA) |
United States |
$0.207B |
0.00 |
LogicBio Therapeutics (LOGC) |
United States |
$0.205B |
0.00 |
Kindred Biosciences (KIN) |
United States |
$0.204B |
0.00 |
TELA Bio (TELA) |
United States |
$0.201B |
0.00 |
GENFIT S.A (GNFT) |
France |
$0.194B |
0.00 |
POXEL SA FRANCE (PXXLF) |
France |
$0.193B |
0.00 |
Aptinyx (APTX) |
United States |
$0.188B |
0.00 |
OSMOTICA PHARM (OSMT) |
United States |
$0.186B |
0.00 |
VolitionRX (VNRX) |
United States |
$0.182B |
0.00 |
Eton Pharmaceuticals (ETON) |
United States |
$0.181B |
0.00 |
Nicox SA (NICXF) |
France |
$0.176B |
0.00 |
AVEO Pharmaceuticals (AVEO) |
United States |
$0.175B |
0.00 |
Voyager Therapeutics (VYGR) |
United States |
$0.173B |
4.84 |
DiaMedica Therapeutics (DMAC) |
United States |
$0.173B |
0.00 |
Applied Genetic Technologies (AGTC) |
United States |
$0.171B |
0.00 |
Exicure (XCUR) |
United States |
$0.170B |
0.00 |
Strongbridge Biopharma (SBBP) |
United States |
$0.168B |
0.00 |
INmune Bio (INMB) |
United States |
$0.168B |
0.00 |
Antibe Therapeutics (ATBPF) |
Canada |
$0.167B |
0.00 |
Chiasma (CHMA) |
United States |
$0.167B |
0.00 |
ObsEva SA (OBSV) |
Switzerland |
$0.163B |
0.00 |
Enzo Biochem (ENZ) |
United States |
$0.161B |
0.00 |
Biofrontera AG (BFRA) |
Germany |
$0.160B |
0.00 |
Catalyst Biosciences (CBIO) |
United States |
$0.157B |
0.00 |
Abeona Therapeutics (ABEO) |
United States |
$0.153B |
0.00 |
Clearside Biomedical (CLSD) |
United States |
$0.151B |
0.00 |
ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.148B |
0.00 |
X4 Pharmaceuticals (XFOR) |
United States |
$0.147B |
0.00 |
Erytech Pharma SA (ERYP) |
France |
$0.144B |
0.00 |
Dyadic (DYAI) |
United States |
$0.142B |
0.00 |
Pluristem Therapeutics (PSTI) |
Israel |
$0.141B |
0.00 |
Eyenovia (EYEN) |
United States |
$0.141B |
0.00 |
Evofem Biosciences (EVFM) |
United States |
$0.139B |
0.00 |
Palatin Technologies (PTN) |
United States |
$0.136B |
0.00 |
Pieris Pharmaceuticals (PIRS) |
United States |
$0.133B |
0.00 |
Synlogic (SYBX) |
United States |
$0.132B |
0.00 |
Orgenesis (ORGS) |
United States |
$0.130B |
267.00 |
Liminal BioSciences (LMNL) |
Canada |
$0.129B |
0.00 |
Galena Biopharma (SLS) |
United States |
$0.127B |
0.00 |
TRACON Pharmaceuticals (TCON) |
United States |
$0.124B |
0.00 |
Aytu BioPharma (AYTU) |
United States |
$0.121B |
0.00 |
Evogene (EVGN) |
Israel |
$0.117B |
0.00 |
ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.116B |
0.00 |
Novogen (KZIA) |
Australia |
$0.115B |
0.00 |
Zosano Pharma (ZSAN) |
United States |
$0.114B |
0.00 |
Beyond Air (XAIR) |
United States |
$0.111B |
0.00 |
Aptevo Therapeutics (APVO) |
United States |
$0.111B |
0.00 |
Liquidia Technologies (LQDA) |
United States |
$0.111B |
0.00 |
Cleveland BioLabs (CBLI) |
United States |
$0.108B |
0.00 |
Ecology Coatings (ABVC) |
United States |
$0.107B |
0.00 |
ARAVIVE, INC (ARAV) |
United States |
$0.106B |
0.00 |
Armata Pharmaceuticals (ARMP) |
United States |
$0.105B |
0.00 |
Cidara Therapeutics (CDTX) |
United States |
$0.104B |
0.00 |
Leap Therapeutics (LPTX) |
United States |
$0.103B |
0.00 |
Celyad SA (CYAD) |
Belgium |
$0.097B |
0.00 |
PHASEBIO PHARMA (PHAS) |
United States |
$0.097B |
0.00 |
Celsion (CLSN) |
United States |
$0.095B |
0.00 |
Lumos Pharma (LUMO) |
United States |
$0.094B |
0.00 |
Cocrystal Pharma (COCP) |
United States |
$0.093B |
0.00 |
Cyclerion Therapeutics (CYCN) |
United States |
$0.092B |
0.00 |
F-star Therapeutics (FSTX) |
United Kingdom |
$0.088B |
0.00 |
Vascular Biogenics (VBLT) |
Israel |
$0.086B |
0.00 |
AIkido Pharma (AIKI) |
United States |
$0.084B |
0.00 |
CollPlant Biotechnologies (CLGN) |
Israel |
$0.083B |
0.00 |
Adocia (ADOCY) |
France |
$0.077B |
0.00 |
CytRx (CYTR) |
United States |
$0.077B |
0.00 |
Vaccinex (VCNX) |
United States |
$0.072B |
0.00 |
Purple Biotech (PPBT) |
Israel |
$0.071B |
0.00 |
Edesa Biotech (EDSA) |
Canada |
$0.071B |
0.00 |
Stealth BioTherapeutics (MITO) |
Cayman Islands |
$0.070B |
0.00 |
Timber Pharmaceuticals (TMBR) |
United States |
$0.070B |
0.00 |
Advaxis (ADXS) |
United States |
$0.069B |
0.00 |
BioCardia (BCDA) |
United States |
$0.069B |
0.00 |
Emmaus Life Sciences (EMMA) |
United States |
$0.066B |
0.00 |
Organovo Holdings (ONVO) |
United States |
$0.065B |
0.00 |
Genetic Technologies (GENE) |
Australia |
$0.064B |
0.00 |
AnPac Bio-Medical Science (ANPC) |
China |
$0.063B |
0.00 |
AEterna Zentaris (AEZS) |
United States |
$0.060B |
0.00 |
Windtree Therapeutics (WINT) |
United States |
$0.060B |
0.00 |
ATyr Pharma (LIFE) |
United States |
$0.060B |
0.00 |
ARIDIS PHARMACT (ARDS) |
United States |
$0.060B |
0.00 |
Alimera Sciences (ALIM) |
United States |
$0.059B |
0.00 |
Aerpio Pharmaceuticals (ARPO) |
United States |
$0.059B |
0.00 |
ZIVO Bioscience (ZIVO) |
United States |
$0.058B |
0.00 |
Soligenix (SNGX) |
United States |
$0.058B |
0.00 |
Pulmatrix (PULM) |
United States |
$0.055B |
0.00 |
Enzon Pharmaceuticals (ENZN) |
United States |
$0.052B |
0.00 |
Enveric Biosciences (ENVB) |
United States |
$0.050B |
0.00 |
Happiness Biotech Group (HAPP) |
China |
$0.049B |
0.00 |
Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.049B |
0.00 |
Idera Pharmaceuticals (IDRA) |
United States |
$0.049B |
0.00 |
Yumanity Therapeutics (YMTX) |
United States |
$0.046B |
0.00 |
Cyclo Therapeutics (CYTH) |
United States |
$0.045B |
0.00 |
Clene (CLNN) |
United States |
$0.043B |
0.00 |
Invo BioScience (INVO) |
United States |
$0.042B |
0.00 |
PLANET GREEN HOLDINGS CORP (PLAG) |
China |
$0.042B |
0.00 |
Vyant Bio (VYNT) |
United States |
$0.040B |
0.00 |
Acorda Therapeutics (ACOR) |
United States |
$0.039B |
0.59 |
Sonnet BioTherapeutics Holdings (SONN) |
United States |
$0.037B |
0.00 |
GeoVax Labs (GOVX) |
United States |
$0.037B |
0.00 |
Vallon Pharmaceuticals (VLON) |
United States |
$0.035B |
0.00 |
IMMURON (IMRN) |
Australia |
$0.032B |
0.00 |
ThermoGenesis Holdings (THMO) |
United States |
$0.031B |
0.00 |
Prana Biotechnology (ATHE) |
Australia |
$0.028B |
0.00 |
Seneca Biopharma (SNCA) |
United States |
$0.026B |
0.00 |
Lexaria Bioscience (LEXX) |
Canada |
$0.026B |
0.00 |
Titan Pharmaceuticals (TTNP) |
United States |
$0.024B |
0.00 |
Benitec Biopharma (BNTC) |
United States |
$0.024B |
0.00 |
Brooklyn ImmunoTherapeutics (BTX) |
United States |
$0.009B |
0.00 |
China Biologic Products (CBPO) |
China |
$0.000B |
29.35 |
Entera Bio (ENTX) |
Israel |
$0.000B |
0.00 |
ImmunityBio (IBRX) |
United States |
$0.000B |
0.00 |
Immatics (IMTX) |
United States |
$0.000B |
0.00 |
Viridian Therapeutics (VRDN) |
United States |
$0.000B |
0.00 |